Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Wandeler

Showing results (11-20 of 201) with videos related to

Pageof 21
Sort By:
AIDS (London, England)|March 2, 2018
Fewer pills do not mean fewer drug-drug interactions: severe rhabdomyolysis on Elvitegravir/Cobicistat and statin treatmentCarlo Perrone, Andri Rauch, Hansjakob Furrer, et al.
Expert Review of Clinical Pharmacology|July 5, 2019
A closer look at the spectrum of drug-induced liver injury in sub-Saharan AfricaCarlotta Riebensahm, Daye Ka, Abdoul Sow, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 14, 2015
Response to 'Is AST-to-platelet ratio index a reliable tool in HIV patients in Africa?'Michael J Vinikoor, Edford Sinkala, Gilles Wandeler, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 26, 2015
Performance of HBsAg point-of-care tests for detection of diagnostic escape-variants in clinical samplesCédric Hirzel, Stefan Pfister, Meri Gorgievski-Hrisoho, et al.
Hepatology (Baltimore, Md.)|July 19, 2018
Hepatitis B Therapy as HIV Prevention in Africa: A Case Series From ZambiaMichael J Vinikoor, Edford Sinkala, Belinda Chihota, et al.
Journal of the International AIDS Society|June 14, 2016
Hepatitis C in HIV-infected individuals: a systematic review and meta-analysis of estimated prevalence in AfricaTiago Castro Lopes Azevedo, Marcel Zwahlen, Andri Rauch, et al.
Lancet (London, England)|March 7, 2018
Issues with measuring hepatitis prevalence in resource-limited settingsGilles Wandeler, Patrick A Coffie, Mark H Kuniholm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2018
No Impact of Hepatitis B Virus Infection on Early Mortality Among Human Immunodeficiency Virus-Infected Patients in Southern AfricaJonas Hector, Michael Vinikoor, Roma Chilengi, et al.
Swiss Medical Weekly|August 22, 2016
Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do betterKatharine Ea Darling, Anna Hachfeld, Matthias Cavassini, et al.
The Lancet. Gastroenterology & Hepatology|December 14, 2024
Eligibility for antiviral therapy in Senegal according to 2024 WHO hepatitis B guidelinesBruce Shinga Wembulua, Adrià Ramírez Mena, Ndeye Fatou Ngom, et al.
Pageof 21

Showing results (11-20 of 201) with videos related to

Sort By:
Pageof 21
AIDS (London, England)|March 2, 2018
Fewer pills do not mean fewer drug-drug interactions: severe rhabdomyolysis on Elvitegravir/Cobicistat and statin treatmentCarlo Perrone, Andri Rauch, Hansjakob Furrer, et al.
Expert Review of Clinical Pharmacology|July 5, 2019
A closer look at the spectrum of drug-induced liver injury in sub-Saharan AfricaCarlotta Riebensahm, Daye Ka, Abdoul Sow, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 14, 2015
Response to 'Is AST-to-platelet ratio index a reliable tool in HIV patients in Africa?'Michael J Vinikoor, Edford Sinkala, Gilles Wandeler, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 26, 2015
Performance of HBsAg point-of-care tests for detection of diagnostic escape-variants in clinical samplesCédric Hirzel, Stefan Pfister, Meri Gorgievski-Hrisoho, et al.
Hepatology (Baltimore, Md.)|July 19, 2018
Hepatitis B Therapy as HIV Prevention in Africa: A Case Series From ZambiaMichael J Vinikoor, Edford Sinkala, Belinda Chihota, et al.
Journal of the International AIDS Society|June 14, 2016
Hepatitis C in HIV-infected individuals: a systematic review and meta-analysis of estimated prevalence in AfricaTiago Castro Lopes Azevedo, Marcel Zwahlen, Andri Rauch, et al.
Lancet (London, England)|March 7, 2018
Issues with measuring hepatitis prevalence in resource-limited settingsGilles Wandeler, Patrick A Coffie, Mark H Kuniholm, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2018
No Impact of Hepatitis B Virus Infection on Early Mortality Among Human Immunodeficiency Virus-Infected Patients in Southern AfricaJonas Hector, Michael Vinikoor, Roma Chilengi, et al.
Swiss Medical Weekly|August 22, 2016
Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do betterKatharine Ea Darling, Anna Hachfeld, Matthias Cavassini, et al.
The Lancet. Gastroenterology & Hepatology|December 14, 2024
Eligibility for antiviral therapy in Senegal according to 2024 WHO hepatitis B guidelinesBruce Shinga Wembulua, Adrià Ramírez Mena, Ndeye Fatou Ngom, et al.
Pageof 21